Home › Funds › Charles Schwab Investment Management › BCLI
Charles Schwab Investment Management position in BCLI
BRAINSTORM CELL THERAPEUTICS
Latest position (Q3 2023)11.29K sh
Reported value held$2.26K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 11.29K | $38.00K | New |
| Q4 2021 | 11.29K | $46.00K | Hold |
| Q1 2022 | 11.29K | $38.00K | Hold |
| Q2 2022 | 11.29K | $32.00K | Hold |
| Q3 2022 | 11.29K | $50.00K | Hold |
| Q4 2022 | 11.29K | $18.51K | Hold |
| Q1 2023 | 11.29K | $37.25K | Hold |
| Q2 2023 | 11.29K | $23.25K | Hold |
| Q3 2023 | 11.29K | $2.26K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.